Business
Press Release Jan 13 2021
Granules India Limited has informed the Exchange regarding a press release dated January 13, 2021, titled "Granules India Limited announces USFDA approval of Metformin Hydrochloride ER Tablets USP, 500 mg and 1000 mg".
About this update from Granules India Limited
[{"type":"text","content":" Granules India Limited has informed the Exchange regarding a press release dated January 13, 2021, titled \"Granules India Limited announces USFDA approval of Metformin Hydrochloride ER Tablets USP, 500 mg and 1000 mg\". View Attachment","length":357,"tagName":"div"}]